These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26093887)

  • 1. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
    Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
    Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
    Sutter I; Klingenberg R; Othman A; Rohrer L; Landmesser U; Heg D; Rodondi N; Mach F; Windecker S; Matter CM; Lüscher TF; von Eckardstein A; Hornemann T
    Atherosclerosis; 2016 Mar; 246():130-40. PubMed ID: 26773473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
    Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
    Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
    Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
    J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
    Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
    J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
    Matsuo Y; Miura S; Kawamura A; Uehara Y; Rye KA; Saku K
    Atherosclerosis; 2007 Sep; 194(1):159-68. PubMed ID: 17118370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
    Kratzer A; Giral H; Landmesser U
    Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
    Vonbank A; Saely CH; Rein P; Drexel H
    Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of lipoprotein-specific lipids in patients with acute coronary syndrome by asymmetrical flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.
    Lee JH; Yang JS; Lee SH; Moon MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1099():56-63. PubMed ID: 30243114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis.
    Sattler K; Lehmann I; Gräler M; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
    Cell Physiol Biochem; 2014; 34(1):172-84. PubMed ID: 24977490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein.
    Rasmiena AA; Barlow CK; Ng TW; Tull D; Meikle PJ
    Biochim Biophys Acta; 2016 Feb; 1861(2):69-77. PubMed ID: 26569052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients.
    Carnuta MG; Stancu CS; Toma L; Sanda GM; Niculescu LS; Deleanu M; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
    Sci Rep; 2017 Aug; 7(1):7295. PubMed ID: 28779156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease.
    Chang CT; Shen MY; Hsieh JY; Chang CM; Liao HY; Chen FY; Hsu CY; Yang CY; Chen CJ
    Atherosclerosis; 2018 Nov; 278():147-155. PubMed ID: 30278357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.
    Keul P; Polzin A; Kaiser K; Gräler M; Dannenberg L; Daum G; Heusch G; Levkau B
    FASEB J; 2019 Jan; 33(1):1482-1495. PubMed ID: 30130432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
    Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA
    Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.